EDIT:NASDAQ
Editas Medicine Inc
2,49 US$
arrow_downward
-0,80%(-0,020) 1K
22-okt, 15:19:49 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,47 US$
Yuqori
2,58 US$
Past
2,45 US$
Bozor kapitali
382,38 mln
Oʻrtacha hajm
2,97 mln
Hajmi
724,30 ming
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Ochish
2,47 US$
Yuqori
2,58 US$
Past
2,45 US$
Bozor kapitali
382,38 mln
Oʻrtacha hajm
2,97 mln
Hajmi
724,30 ming
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
CNBC
·
57 daqiqa oldin
The perfect storm behind the Nasdaq's rout — plus, some of the bright spots in the market
The Motley Fool
·
9 daqiqa oldin
The Stock Market Sounds an Alarm for the First Time in Nearly 27 Years. Here Is What History Says the S&P 500 Will Do Next.
Markets Media
·
22 daqiqa oldin
Nasdaq Advances Shift Towards More Connected Always-On Markets
Bloomberg.com
·
15 daqiqa oldin
US Futures Slip as Risk-Off Sentiment Dominates With Oil Rising
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida